This article covers common aesthetic treatment options as of publication in September 2026. Product availability, FDA-cleared indications, and best practices continue to evolve. Consult with a board-certified provider before making any treatment decision. Nothing in this article is medical advice for your specific situation.
Rapid weight loss on GLP-1 medications produces a familiar and unwelcome side effect: the face gets thinner along with the rest of the body, and the face rarely gets thinner in flattering proportions. Volume loss shows up in the cheeks, temples, under-eyes, and jawline. Skin that was previously supported by fat pads loses its underlying structure and starts to look loose. The overall effect — hollowed features, deeper folds, more visible bone structure — reads as accelerated aging even in patients whose weight loss is otherwise a health success.
The aesthetic industry has developed a category label for this: "Ozempic face." The name is inexact (the same effect occurs after any rapid substantial weight loss, whether pharmacologic or through bariatric surgery or extended calorie restriction), but the phenomenon is real, and 2026 has seen a corresponding surge in aesthetic consultation for volume restoration among GLP-1 users.
This piece walks through what actually causes the changes, the treatment categories that address them, and what to look for when choosing a provider.
What causes the facial changes
The face carries fat in a series of distinct compartments — cheeks, temples, periorbital, perioral, jawline, and others. Each compartment contributes to the youthful contours the face displays in early adulthood. Weight loss depletes fat from these compartments along with fat everywhere else in the body, and because facial fat compartments are relatively small, meaningful percentage-of-total losses show up quickly.
The visible changes commonly include:
•Cheek hollowing as the malar and buccal fat pads shrink
•Temple hollowing as the temporal fat pad thins
•Under-eye hollows as the periorbital fat pads deflate
•Nasolabial fold deepening as cheek support decreases
•Marionette line development as perioral support decreases
•Jawline redefinition — sometimes appearing more defined initially, then losing definition as skin laxity increases
•Skin laxity — the previously stretched skin does not fully retract to fit the smaller underlying volume
The changes are not universal; individual anatomy, age, rate of weight loss, and prior aesthetic history all affect how prominent the changes become. A patient in their thirties who loses weight gradually often shows less facial volume loss than a patient in their fifties who loses the same amount rapidly.
The treatment categories
Aesthetic treatments for post-GLP-1 volume loss fall into four categories, each addressing a different aspect of the problem:
Biostimulators that trigger the body's own collagen production over months. Sculptra (poly-L-lactic acid) is the primary example.
Volumizing fillers that provide immediate structural support with longer-duration materials. Radiesse (calcium hydroxylapatite) is the primary example.
Hyaluronic acid (HA) fillers that provide immediate volume with reversibility. Juvederm, Restylane, and RHA collection are common product lines.
Skin quality treatments that address laxity and texture rather than volume. RF microneedling (Morpheus8, Vivace, Genius) and PRF are common options.
Most volume-restoration treatment plans for GLP-1 patients combine categories rather than relying on a single product. Understanding what each category does — and what it does not do — is the starting point for evaluating a treatment recommendation.
Sculptra: the biostimulator approach
Sculptra is an injectable poly-L-lactic acid (PLLA) product FDA-approved as a biostimulator. Unlike traditional fillers, Sculptra does not primarily add immediate volume. Instead, it stimulates the patient's own fibroblasts to produce new collagen over three to six months. The result develops gradually as new collagen forms.
Sculptra fits well for post-GLP-1 patients because the volume loss is typically diffuse rather than localized, and Sculptra distributes its effect across a broad area rather than creating discrete pockets of volume. Typical protocols involve two to three treatment sessions spaced four to six weeks apart, with results developing progressively over the following months and typically lasting two to three years or longer.
The trade-offs: the delayed results require patience — a patient expecting immediate change will be disappointed at the first appointment. Nodule formation is a known potential complication when Sculptra is not properly reconstituted or injected. Provider technique matters more with Sculptra than with many alternatives.
Radiesse: immediate structure with collagen stimulation
Radiesse is an injectable calcium hydroxylapatite (CaHA) product with dual mechanisms: it provides immediate volume through the CaHA microspheres themselves, and it stimulates collagen production around the microspheres over time. It is FDA-approved for correction of moderate-to-severe facial wrinkles and folds.
For post-GLP-1 volume restoration, Radiesse fits well for structural areas where a firmer, more defining product is appropriate — jawline definition, cheek projection, and pre-jowl support. Results are visible immediately and typically last 12 to 18 months, with the collagen-stimulation effect potentially extending duration.
The trade-offs: Radiesse is not reversible in the way HA fillers are. Once injected, it must be waited out or, in some cases, addressed with dissolving techniques that are less clean than HA reversal. The firmness that makes Radiesse good for structural areas makes it less suitable for delicate areas like lips or tear troughs.
Hyaluronic acid fillers: reversible and versatile
HA fillers are the most widely used aesthetic injectables in the United States. Juvederm (Voluma, Volbella, Vollure, Ultra, Ultra Plus), Restylane (Lyft, Defyne, Refyne, Kysse, Contour), and the RHA collection (RHA 2, 3, 4, and Redensity) offer a range of product characteristics from very soft (lip products) to firm and lifting (deep tissue products).
For post-GLP-1 patients, HA fillers frequently serve as the versatile workhorse across multiple facial regions. Voluma or Restylane Lyft for cheek projection, Volbella or RHA Redensity for tear troughs, Juvederm Ultra or Restylane for lips and perioral areas, and so on. Results are immediate. Duration ranges from about 6 to 18 months depending on the product and area treated.
The reversibility advantage is significant. If a patient does not like the result, or if a complication develops, HA fillers can be dissolved with hyaluronidase — usually in a single office visit. This safety valve does not exist with biostimulators or Radiesse.
The trade-offs: HA fillers require more frequent maintenance than biostimulators. Over-injection is more visible with HA fillers because the immediate results are visible immediately, and the "overfilled" look that has become a subject of aesthetic-industry conversation in 2025-2026 is most commonly an HA-filler outcome.
Skin quality treatments: RF microneedling and PRF
Volume alone does not restore a face fully affected by rapid weight loss. Skin quality — laxity, texture, tone — matters alongside volume, and volume restoration without addressing skin quality often produces a result that is fuller but not younger.
RF microneedling devices (Morpheus8, Vivace, Genius, Sylfirm X) combine mechanical microneedling with radiofrequency energy delivered into the dermis. The RF energy stimulates collagen and elastin production, tightens existing collagen, and improves skin texture over a series of treatments. Typical protocols involve three sessions spaced four to six weeks apart, with progressive improvement over several months.
RF microneedling fits well for post-GLP-1 patients with visible skin laxity and mild-to-moderate texture concerns. It works well in combination with volume restoration — the volume products restore structure, and RF microneedling improves the quality of the skin covering that structure.
Platelet-rich fibrin (PRF) is an autologous product derived from the patient's own blood. It contains platelets and growth factors in a fibrin matrix, and can be injected or applied topically after procedures like microneedling. PRF is not FDA-regulated as a drug because it is autologous and minimally manipulated. Evidence for aesthetic use is more mixed than for the volume-restoration categories, but many providers use PRF as an adjunct treatment for skin quality improvement, hair restoration, and post-procedure recovery.
Combining approaches
Most experienced aesthetic providers building a treatment plan for post-GLP-1 volume loss will combine categories. A typical plan might involve:
•Sculptra across the mid-face for gradual overall volume restoration
•HA filler in specific areas requiring immediate correction (tear troughs, lips)
•Radiesse for jawline definition and pre-jowl support if warranted
•RF microneedling series for skin quality
•Optional PRF as an adjunct at treatment sessions
The specific combination depends on the patient's anatomy, degree of volume loss, budget, and treatment timeline. A patient who wants to see meaningful change within a month will need immediate-effect products (HA, Radiesse) rather than relying on biostimulators alone. A patient with a longer horizon may prefer to build with biostimulators and add spot corrections with HA as needed.
What to look for in a provider
Post-GLP-1 volume restoration is more complex than a single-product treatment because the underlying changes are more diffuse. The provider criteria that matter:
Board certification in a relevant specialty — plastic surgery, dermatology, facial plastic surgery, or oculoplastic surgery (for periorbital work). Advanced practice providers under proper physician oversight can also perform many of these treatments; the physician oversight structure matters.
Experience with each product category the provider recommends. A provider who only uses HA fillers may recommend HA for everything even when a biostimulator would fit better. A provider comfortable across all categories has more options to match the patient's specific situation.
A conservative approach that starts smaller. For post-weight-loss patients specifically, restoration to prior appearance often requires less product than the volume loss might suggest — the face has a different structural relationship after weight loss and over-restoration can look unnatural. Providers who default to conservative starting doses and build over multiple sessions are frequently a better fit than providers who advocate for large single-session corrections.
Willingness to discuss what treatments cannot fix. Skin laxity beyond a certain degree does not respond fully to RF microneedling; the patient needs to know this before starting a treatment series that will disappoint them. Volume restoration cannot fully replicate the fat distribution pattern of a face that never lost the weight. A provider who is candid about limitations is a better long-term partner than one who promises everything.
A clear pricing structure. Multi-modality treatment plans can become expensive quickly. Understanding the full cost — including likely maintenance intervals — before committing to a treatment path is worth the pre-treatment conversation.
Documented product sourcing. In 2025-2026 the aesthetic industry has seen increased concerns about counterfeit injectable products in some markets. A provider who can document that their products come from authorized distribution channels is preferable to one who cannot or will not.
What to ask at the consultation
Four questions worth asking at a consultation:
One: what is your recommendation and why this combination? The answer should reference the specific volume loss pattern you have and match the treatments to that pattern, not offer a one-size-fits-all package.
Two: what results should I expect at three months, six months, and one year? Realistic timelines matter. A provider who cannot describe expected progression is one who has not thought carefully about your specific case.
Three: what is the total cost, and what maintenance will this require? Both the initial series and the ongoing cost.
Four: what happens if I am not happy with the result? For HA fillers, the answer includes dissolving. For biostimulators and Radiesse, the answer is more limited. Understanding the answer before treatment matters.
For a treatment plan of this complexity, a provider who is comfortable across multiple categories is worth more than one who defaults to a single approach for every patient.
This article is educational and does not constitute medical advice. Always consult a licensed medical professional for personalized recommendations.
Looking for a dermal fillers provider?